Lipid management in patients with diabetes mellitus

American Journal of Cardiology

Volumn 96, Issue 4 SUPPL., 2005, Pages 26-32

  Brown, Alan S ^a,b  

^a Midwest Heart Spec Dis Prev Ctr   (United States)

^b Midwest Heart Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN;

ATHEROSCLEROSIS; BEHAVIOR MODIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; COUNSELING; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SURVIVAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 23744468392     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.07.001     Document Type: Conference Paper

References (22)

1. S.J. Kenny, R.E. Aubert, L.S. Geiss Prevalence and incidence of non-insulin dependent diabetes. National Diabetes Data Group (US) M. Harris Diabetes in America 2nd ed 1995 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 47 68 NIH publication 96-1468
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
3. [East West Study - source of figure 1]
4. S.M. Haffner, M.P. Stern, H.P. Hazuda, B.D. Mitchell, J.K. Patterson Cardiovascular risk factors in confirmed prediabetic individuals does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263 1990 2893 2898
5. G.F. Lewis Diabetic dyslipidemia a case for aggressive intervention in the absence of clinical trial and cost effectiveness data Can J Cardiol 11 suppl C 1995 24C 28C
6. D. Levy, P.W.F. Wilson Atherosclerotic cardiovascular disease an epidemiologic perspective E.J. Topol Text of Cardiovascular Medicine 1998 Lippincott-Raven Philadelphia, PA 13 30
7. E. Eschwege, J.L. Richard, N. Thibult, P. Ducimetiere, J.M. Warnet, J.R. Claude, G.E. Rosselin Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels the Paris Prospective Study, ten years later Horm Metab Res Suppl 15 1985 41 46
8. H. Miettinen, S. Lehto, V. Salomaa, M. Mahonen, M. Niemela, S.M. Haffner, K. Pyorala, J. Tuomilehto Impact of diabetes on mortality after the first myocardial infarction the FINMONICA Myocardial Infarction Register Study Group Diabetes Care 21 1998 69 75
9. J.M. Sprafka, G.L. Burke, A.R. Folsom, P.G. McGovern, L.P. Hahn Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey Diabetes Care 14 1991 537 543
10. J. Stamler, O. Vaccaro, J.D. Neaton, D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
11. J. Kuusisto, L. Mykkänen, K. Pyönlärä, S.N. Laakso NIDDM and its metabolic control control predict coronary heart disease in elderly subjects Diabetes 43 1994 960 967
12. United Kingdom Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
13. B.V. Howard, D.C. Robbins, M.L. Sievers, E.T. Lee, D. Rhoades, R.B. Devereau, L.D. Cowan, R.S. Gray, T.K. Welty, O.T. Go LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL the Strong Heart Study Arterioscl Thromb Vasc Biol 20 2000 830
14. The Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
15. K. Pyorala, T.R. Pedersen, J. Kjekshus, O. Faergeman, A.G. Olsson, G. Thorgeirsson Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620
16. MRC/BHF Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering in 20,536 high-risk individuals a randomized placebo controlled trial Lancet 360 2002 7 22
17. MRC/BHF Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death early safety and efficacy experience Eur Heart J 20 1999 725 741
18. R. Collins, J. Armitage, S. Parish, P. Sleigh, R. Peto Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes a randomized placebo-controlled trial Lancet 361 2003 2005 2016
19. H.M. Colhoun, D.J. Betteridge, P.N. Durrington, G.A. Hitman, H.A.W. Neil, S.J. Livingstone, M.J. Thomason, M.I. Mackness, V. Charlton-Menys, J.H. Fuller CARDS investigators Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) multicentre randomized placebo-controlled trial Lancet 364 2004 685 696
20. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
21. J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350
22. A.S. Brown Use of combination therapy for dyslipidemia a lipid clinic approach Am J Cardiol 90 suppl 10B 2002 44K 49K